Ortin Laboratories Ltd Quarterly Results

Gross Sales

13.16

17.46

18.41

Excise Duty

0

0

0

Net Sales

13.16

17.46

18.41

Other Operating Income

2.77

2.31

1.4

Other Income

0.03

0.19

0.01

Total Income

15.96

19.96

19.82

Total Expenditure

13.85

20.77

17.13

PBIDT

2.11

-0.81

2.69

Interest

1.12

0.98

0.55

PBDT

0.99

-1.79

2.14

Depreciation

0.33

0.39

0.34

Minority Interest Before NP

0

0

0

Tax

0.22

-0.26

0.6

Deferred Tax

0

0

0

Reported Profit After Tax

0.44

-1.92

1.2

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

0.44

-1.92

1.2

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

0.44

-1.92

1.2

EPS (Unit Curr.)

0.26

-1.13

0.71

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

16.94

16.94

16.94

Public Shareholding (Number)

6,87,652

66,08,699

64,38,926

Public Shareholding (%)

40.61

39.01

38.01

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

1,00,61,748

1,03,31,701

1,05,01,474

Non Encumbered - % in Total Promoters Holding

100

100

100

Non Encumbered - % in Total Equity

59.39

60.99

61.99

PBIDTM(%)

16.03

-4.63

14.61

PBDTM(%)

7.52

-10.25

11.62

PATM(%)

3.34

-10.99

6.51